Exane Derivatives’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $256K | Sell |
790
-1,691
| -68% | -$548K | 0.15% | 141 |
|
|
2022
Q1 | $710K | Buy |
2,481
+688
| +38% | +$197K | 0.2% | 132 |
|
|
2021
Q4 | $495K | Buy |
1,793
+43
| +2% | +$11.9K | 0.12% | 178 |
|
|
2021
Q3 | $404K | Buy |
1,750
+252
| +17% | +$58.2K | 0.1% | 215 |
|
|
2021
Q2 | $352K | Buy |
1,498
+101
| +7% | +$23.8K | 0.08% | 241 |
|
|
2021
Q1 | $261K | Sell |
1,397
-2,653
| -66% | -$496K | 0.07% | 246 |
|
|
2020
Q4 | $684K | Buy |
4,050
+2,932
| +262% | +$495K | 0.2% | 105 |
|
|
2020
Q3 | $165K | Sell |
1,118
-2,695
| -71% | -$399K | 0.05% | 214 |
|
|
2020
Q2 | $626K | Sell |
3,813
-1,550
| -29% | -$254K | 0.17% | 101 |
|
|
2020
Q1 | $744K | Sell |
5,363
-411
| -7% | -$57K | 0.21% | 88 |
|
|
2019
Q4 | $815K | Sell |
5,774
-763
| -12% | -$108K | 0.15% | 109 |
|
|
2019
Q3 | $731K | Buy |
6,537
+5,549
| +562% | +$620K | 0.13% | 121 |
|
|
2019
Q2 | $109K | Buy |
988
+70
| +8% | +$7.75K | 0.02% | 310 |
|
|
2019
Q1 | $119K | Sell |
918
-8,717
| -90% | -$1.13M | 0.02% | 265 |
|
|
2018
Q4 | $1.11M | Sell |
9,635
-2,329
| -19% | -$269K | 0.2% | 102 |
|
|
2018
Q3 | $1.28M | Sell |
11,964
-3,166
| -21% | -$340K | 0.24% | 85 |
|
|
2018
Q2 | $1.29M | Sell |
15,130
-1,227
| -8% | -$105K | 0.22% | 89 |
|
|
2018
Q1 | $1.26M | Sell |
16,357
-2,330
| -12% | -$179K | 0.25% | 92 |
|
|
2017
Q4 | $1.58M | Buy |
18,687
+18,051
| +2,838% | +$1.52M | 0.27% | 59 |
|
|
2017
Q3 | $54.4K | Sell |
636
-3,055
| -83% | -$261K | 0.01% | 271 |
|
|
2017
Q2 | $304K | Sell |
3,691
-1,675
| -31% | -$138K | 0.07% | 159 |
|
|
2017
Q1 | $451K | Sell |
5,366
-12,426
| -70% | -$1.05M | 0.1% | 130 |
|
|
2016
Q4 | $1.31M | Buy |
17,792
+16,897
| +1,888% | +$1.24M | 0.26% | 67 |
|
|
2016
Q3 | $71.8K | Sell |
895
-2,584
| -74% | -$207K | 0.01% | 237 |
|
|
2016
Q2 | $274K | Sell |
3,479
-2,396
| -41% | -$189K | 0.05% | 179 |
|
|
2016
Q1 | $423K | Buy |
5,875
+3,653
| +164% | +$263K | 0.06% | 128 |
|
|
2015
Q4 | $187K | Buy |
+2,222
| New | +$187K | 0.03% | 144 |
|